Department of Clinical and Experimental Medicine, Pharmacology Unit, University of Ferrara, via Fossato di Mortara 17-19, 44100 Ferrara, Italy.
FASEB J. 2010 Apr;24(4):1192-204. doi: 10.1096/fj.09-139485. Epub 2009 Dec 14.
The primary aim of this study was to investigate adenosine receptors (ARs) in bronchoalveolar lavage (BAL) macrophages from patients with chronic obstructive pulmonary disease (COPD) and age-matched healthy smokers. A(2B)ARs were significantly decreased in BAL macrophages from patients with COPD when compared with healthy smokers. The effect of proinflammatory cytokines and oxidative/nitrosative stress on AR expression and function in U937 cells before and after PMA treatment was evaluated. IL-1beta and TNF-alpha treatment up-regulated A(2A)- and A(3)ARs but not A(1)- or A(2B)ARs, whereas IL-6 did not modify AR expression. In contrast, oxidative/nitrosative stress selectively decreased A(2B)AR expression, which was associated with a reduction in the potency of the adenosine agonist 5'-N-ethylcarboxamideadenosine (NECA) to induce cAMP. Further, the ability of NECA to enhance cell proliferation was increased after oxidative/nitrosative stress. The specific involvement of A(2B)ARs was investigated by using potent and selective A(2B)AR antagonist and by A(2B)AR knockdown using siRNA and demonstrated responses similar to those obtained with oxidative/nitrosative stress. N-acetylcysteine (NAC), an antioxidant agent, counteracted the decrease in A(2B)AR expression, as well as the altered NECA effects on cAMP and cell proliferation. These findings highlight the central role of A(2B)ARs in alveolar macrophages, suggesting that their modulation could represent an innovative pharmacological strategy to manage COPD.-Varani, K., Caramori, G., Vincenzi, F., Tosi, A., Barczyk, A., Contoli, M., Casolari, P., Triggiani, M., Hansel, T., Leung, E., MacLennan, S., Barnes, P. J., Fan Chung, K., Adcock, I., Papi, A., Borea, P. A. Oxidative/nitrosative stress selectively altered A(2B) adenosine receptors in chronic obstructive pulmonary disease.
本研究的主要目的是研究慢性阻塞性肺疾病(COPD)患者和年龄匹配的健康吸烟者支气管肺泡灌洗液(BAL)中的腺苷受体(ARs)。与健康吸烟者相比,COPD 患者的 BAL 巨噬细胞中的 A(2B)AR 显著减少。评估了前体和 PMA 处理后的 U937 细胞中促炎细胞因子和氧化/硝化应激对 AR 表达和功能的影响。IL-1β和 TNF-α处理上调了 A(2A)-和 A(3)ARs,但不调节 A(1)-或 A(2B)ARs,而 IL-6 不改变 AR 表达。相比之下,氧化/硝化应激选择性地降低了 A(2B)AR 的表达,这与腺苷激动剂 5'-N-乙基羧酰胺腺苷(NECA)诱导 cAMP 的效力降低有关。此外,氧化/硝化应激后,NECA 增强细胞增殖的能力增加。通过使用有效的和选择性的 A(2B)AR 拮抗剂以及使用 siRNA 敲低 A(2B)AR,研究了 A(2B)AR 的特定参与,并证明了与氧化/硝化应激获得的反应相似。抗氧化剂 N-乙酰半胱氨酸(NAC)抵消了 A(2B)AR 表达的降低,以及 NECA 对 cAMP 和细胞增殖的改变作用。这些发现突出了 A(2B)AR 在肺泡巨噬细胞中的核心作用,表明其调节可能代表一种管理 COPD 的创新药理学策略。-Varani,K.,Caramori,G.,Vincenzi,F.,Tosi,A.,Barczyk,A.,Contoli,M.,Casolari,P.,Triggiani,M.,Hansel,T.,Leung,E.,MacLennan,S.,Barnes,P. J.,Fan Chung,K.,Adcock,I.,Papi,A.,Borea,P. A. 氧化/硝化应激选择性改变慢性阻塞性肺疾病中的 A(2B)腺苷受体。